ConductScience.org, home

Paper500119

The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

Verbrugh HA and 4 others. Immunology, 1979. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization. Papers, record 500119. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/500119

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.
PubMed
Journal
Immunology
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
1.89
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verbrugh HAH A
2Van Dijk WCW C
3Peters RR
4Van Der Tol MEM E
5Verhoef JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement ActivationMajor topic
Opsonin ProteinsMajor topic
PeptidoglycanMajor topic
Staphylococcal Protein AMajor topic
Staphylococcus aureusMajor topic
Teichoic AcidsMajor topic
Complement C2
Complement C3
Complement Fixation Tests
Kinetics

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121849Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.Infect Immun1977https://conductscience.org/library/papers/21849PubMed
2108204
Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Immunology1979https://conductscience.org/library/papers/108204PubMed
3236357The opsonic fragment of the third component of human complement (C3).J Exp Med1975https://conductscience.org/library/papers/236357PubMed
4344340Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.J Clin Microbiol1978https://conductscience.org/library/papers/344340PubMed
5415969Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.Immunology1977https://conductscience.org/library/papers/415969PubMed
6641141The key role of peptidoglycan in the opsonization of Staphylococcus aureus.J Clin Invest1978https://conductscience.org/library/papers/641141PubMed
7669803Activation of complement by cell surface components of Staphylococcus aureus.Infect Immun1978https://conductscience.org/library/papers/669803PubMed
8670409Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.J Clin Pathol1978https://conductscience.org/library/papers/670409PubMed
9870431Effect of protein A on staphylococcal opsonization.Infect Immun1977https://conductscience.org/library/papers/870431PubMed
101088938Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.Clin Immunol Immunopathol1975https://conductscience.org/library/papers/1088938PubMed
114134581Staphylococcal heat-stable opsonins.J Lab Clin Med1974https://conductscience.org/library/papers/4134581PubMed
124152919Influence of the alternate complement pathway in opsonization of several bacterial species.Infect Immun1974https://conductscience.org/library/papers/4152919PubMed
134796971Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus.Immunochemistry1973https://conductscience.org/library/papers/4796971PubMed
145529399Activation and inhibition of IgG mediated complement fixation by staphylococcal protein A.Clin Exp Immunol1970https://conductscience.org/library/papers/5529399PubMed
155661952Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.Exp Cell Res1968https://conductscience.org/library/papers/5661952PubMed
1616557911Cell Wall Component Which Affects the Ability of Serum to Promote Phagocytosis and Killing of Staphylococcus aureus.Infect Immun1970https://conductscience.org/library/papers/16557911PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
30463950Staphylococcus aureus coagulases are exploitable yet stable public goods in clinically relevant conditions.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/30463950PubMed
27432741Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.J Am Soc Nephrol2017https://conductscience.org/library/papers/27432741PubMed
24039758Application of fluorescent monocytes for probing immune complexes on antigen microarrays.PLoS One2013https://conductscience.org/library/papers/24039758PubMed
21353779A play in four acts: Staphylococcus aureus abscess formation.Trends Microbiol2011https://conductscience.org/library/papers/21353779PubMed
21138841Host chemokines bind to Staphylococcus aureus and stimulate protein A release.J Biol Chem2011https://conductscience.org/library/papers/21138841PubMed
18293486Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry.J Am Soc Mass Spectrom2008https://conductscience.org/library/papers/18293486PubMed
17351618A structural basis for complement inhibition by Staphylococcus aureus.Nat Immunol2007https://conductscience.org/library/papers/17351618PubMed
16239950A comparative analysis of antibody repertoire against Staphylococcus aureus antigens in patients with deep-seated versus superficial staphylococcal infections.Int J Med Sci2005https://conductscience.org/library/papers/16239950PubMed
8945544Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci.Infect Immun1996https://conductscience.org/library/papers/8945544PubMed
8063400Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.Infect Immun1994https://conductscience.org/library/papers/8063400PubMed
7309234Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.Infect Immun1981https://conductscience.org/library/papers/7309234PubMed
7275277Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.Inflammation1981https://conductscience.org/library/papers/7275277PubMed
7216486Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid.Infect Immun1981https://conductscience.org/library/papers/7216486PubMed
7033141In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.Infect Immun1982https://conductscience.org/library/papers/7033141PubMed
6799403Complement consumption gonococcal peptidoglycan.Infect Immun1982https://conductscience.org/library/papers/6799403PubMed
6389361A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.Infect Immun1984https://conductscience.org/library/papers/6389361PubMed
6378796Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.Infect Immun1984https://conductscience.org/library/papers/6378796PubMed
3965410Isolation and partial characterization of staphylococcal decomplementation antigen.Infect Immun1985https://conductscience.org/library/papers/3965410PubMed
3800357Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3800357PubMed
3134203Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum.Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/3134203PubMed

See all 21 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C2717PubTator's text mininghttps://conductscience.org/library/genes/717NCBI Gene
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/500119

GET https://conductscience.org/api/papers/v1/500119/cited_by?page=2